These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

826 related items for PubMed ID: 29851226

  • 1. MicroRNA-1 overexpression increases chemosensitivity of non-small cell lung cancer cells by inhibiting autophagy related 3-mediated autophagy.
    Hua L, Zhu G, Wei J.
    Cell Biol Int; 2018 Sep; 42(9):1240-1249. PubMed ID: 29851226
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. miR-16 mimics inhibit TGF-β1-induced epithelial-to-mesenchymal transition via activation of autophagy in non-small cell lung carcinoma cells.
    Wang H, Zhang Y, Wu Q, Wang YB, Wang W.
    Oncol Rep; 2018 Jan; 39(1):247-254. PubMed ID: 29138833
    [Abstract] [Full Text] [Related]

  • 4. Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7.
    Pan X, Chen Y, Shen Y, Tantai J.
    Cell Death Dis; 2019 Jun 03; 10(6):429. PubMed ID: 31160576
    [Abstract] [Full Text] [Related]

  • 5. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway.
    Xiao XH, He SY.
    Eur Rev Med Pharmacol Sci; 2020 Mar 03; 24(6):3130-3142. PubMed ID: 32271431
    [Abstract] [Full Text] [Related]

  • 6. DICER activates autophagy and promotes cisplatin resistance in non-small cell lung cancer by binding with let-7i-5p.
    Li C, Chen L, Song W, Peng B, Zhu J, Fang L.
    Acta Histochem; 2021 Oct 03; 123(7):151788. PubMed ID: 34543777
    [Abstract] [Full Text] [Related]

  • 7. miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs).
    Liu X, Zhou X, Chen Y, Huang Y, He J, Luo H.
    Neoplasma; 2020 Jan 03; 67(1):147-157. PubMed ID: 31686523
    [Abstract] [Full Text] [Related]

  • 8. miR-375 targeting autophagy-related 2B (ATG2B) suppresses autophagy and tumorigenesis in cisplatin-resistant osteosarcoma cells.
    Gao S, Wang K, Wang X.
    Neoplasma; 2020 Jul 03; 67(4):724-734. PubMed ID: 32726125
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Circ-CUL2/microRNA-888-5p/RB1CC1 axis participates in cisplatin resistance in NSCLC via repressing cell advancement.
    Chen H, Li F, Xue Q.
    Bioengineered; 2022 Feb 03; 13(2):2828-2840. PubMed ID: 35068326
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CircRNA_100565 contributes to cisplatin resistance of NSCLC cells by regulating proliferation, apoptosis and autophagy via miR-337-3p/ADAM28 axis.
    Zhong Y, Lin H, Li Q, Liu C, Shen J.
    Cancer Biomark; 2021 Feb 03; 30(2):261-273. PubMed ID: 33682697
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.
    Li JH, Luo N, Zhong MZ, Xiao ZQ, Wang JX, Yao XY, Peng Y, Cao J.
    Tumour Biol; 2016 Feb 03; 37(2):2387-94. PubMed ID: 26376998
    [Abstract] [Full Text] [Related]

  • 16. MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9.
    Rao C, Miao X, Zhao G, Zhang C, Shen H, Dong C, Yang M.
    Biomed Pharmacother; 2019 Jun 03; 114():108662. PubMed ID: 30999114
    [Abstract] [Full Text] [Related]

  • 17. Up-regulation of microRNA miR-101-3p enhances sensitivity to cisplatin via regulation of small interfering RNA (siRNA) Anti-human AGT4D and autophagy in non-small-cell lung carcinoma (NSCLC).
    Cui D, Feng Y, Qian R.
    Bioengineered; 2021 Dec 03; 12(1):8435-8446. PubMed ID: 34694211
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-106b-5p regulates cisplatin chemosensitivity by targeting polycystic kidney disease-2 in non-small-cell lung cancer.
    Yu S, Qin X, Chen T, Zhou L, Xu X, Feng J.
    Anticancer Drugs; 2017 Sep 03; 28(8):852-860. PubMed ID: 28723865
    [Abstract] [Full Text] [Related]

  • 19. NORAD accelerates chemo-resistance of non-small-cell lung cancer via targeting at miR-129-1-3p/SOX4 axis.
    Huang Q, Xing S, Peng A, Yu Z.
    Biosci Rep; 2020 Jan 31; 40(1):. PubMed ID: 31894841
    [Abstract] [Full Text] [Related]

  • 20. LncRNA SNHG14 regulates the DDP-resistance of non-small cell lung cancer cell through miR-133a/HOXB13 pathway.
    Xu L, Xu Y, Yang M, Li J, Xu F, Chen BL.
    BMC Pulm Med; 2020 Oct 15; 20(1):266. PubMed ID: 33059643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.